LINC00992: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC00992

NCBI ID: G728342

LINC00992

Other Name(s): long intergenic non-protein coding RNA 992 | Long intergenic non-protein coding RNA 992

LINC00992: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC00992 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique feature that it is primarily located within intron 992 of a gene, which means it is named after its position on the DNA sequence. LINC00992 has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Drug Target Potential

LINC00992 has been identified as a potential drug target due to its unique structure and its involvement in cellular processes that are associated with various diseases. One of the most promising aspects of LINC00992 is its role in cancer progression. Studies have shown that LINC00992 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LINC00992 has been shown to promote the growth and survival of cancer cells in cell culture and animal models.

Another potential drug target for LINC00992 is its role in neurodegenerative diseases. Studies have shown that LINC00992 is involved in the regulation of synaptic plasticity, which is the ability of the brain to adapt and change over time. LINC00992 has been shown to play a critical role in the development of neurodegenerative diseases, including Alzheimer's and Parkinson's disease.

Biomarker Potential

In addition to its potential as a drug target, LINC00992 also has the potential as a biomarker. Studies have shown that LINC00992 is expressed in various tissues and cells, including brain, spleen, and peripheral blood cells. Additionally, LINC00992 has been shown to be downregulated in various diseases, including cancer and neurodegenerative diseases. This suggests that LINC00992 may be a useful biomarker for these diseases.

Methodology

To study the potential drug target and biomarker properties of LINC00992, researchers have used a variety of techniques, including RNA sequencing, qRT-PCR, and western blotting. These studies have shown that LINC00992 is a highly expressed lncRNA that is involved in various cellular processes.

Conclusion

In conclusion, LINC00992 is a long non-coding RNA that has been identified in various organisms. It has a unique feature that it is primarily located within intron 992 of a gene, which means it is named after its position on the DNA sequence. LINC00992 has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and transcriptional regulation. Furthermore, LINC00992 has the potential as a drug target and biomarker. Further studies are needed to fully understand the role of LINC00992 in various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 992

The "LINC00992 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00992 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets